Document:

Revolving Loan Promissory Note

 Exhibit 10.23(i) 
 REVOLVING LOAN PROMISSORY NOTE 
 April 30, 2008 
 FOR VALUE RECEIVED, SALIENT SURGICAL TECHNOLOGIES, INC., a Delaware corporation located at the address stated below (“Borrower”), promises to pay to the
order of OXFORD FINANCE CORPORATION or any subsequent holder hereof (each, a “Lender”), the principal sum of Two Million Five Hundred Thousand and 00/100 Dollars ($2,500,000.00) or, if less, the aggregate unpaid principal amount of
all Revolving Loans made by Lender to or on behalf of Borrower pursuant to the Agreement (as hereinafter defined). All capitalized terms, unless otherwise defined herein, shall have the respective meanings assigned to such terms in the Agreement.

 This Promissory Note is issued pursuant to that certain Amended and Restated Loan and Security Agreement, dated as of April 30, 2008, among Borrower,
the guarantors from time to time party thereto, General Electric Capital Corporation, as agent, the other lenders signatory thereto, and Lender (as amended, restated, supplemented or otherwise modified from time to time, the
“Agreement”), is one of the Revolving Notes referred to therein, and is entitled to the benefit and security of the Debt Documents referred to therein, to which Agreement reference is hereby made for a statement of all of the terms
and conditions under which the loans evidenced hereby were made. 
 The principal amount of the indebtedness evidenced hereby shall be payable in the amounts
and on the dates specified in the Agreement. Interest thereon shall be paid until such principal amount is paid in full at such interest rates and at such times as are specified in the Agreement. The terms of the Agreement are hereby incorporated
herein by reference. 
 All payments shall be applied in accordance with the Agreement. The acceptance by Lender of any payment which is less than payment in
full of all amounts due and owing at such time shall not constitute a waiver of Lender’s right to receive payment in full at such time or at any prior or subsequent time. 
 All amounts due hereunder and under the other Debt Documents are payable in the lawful currency of the United States of America. Borrower hereby expressly authorizes Lender to insert the date value as is actually
given in the blank space on the face hereof and on all related documents pertaining hereto. 
 This Note is secured as provided in the Agreement and the
other Debt Documents. Reference is hereby made to the Agreement and the other Debt Documents for a description of the properties and assets in which a security interest has been granted, the nature and extent of the security interest, the terms and
conditions upon which the security interest was granted and the rights of the holder of the Note in respect thereof. 
 Time is of the essence hereof.

 This Note may be voluntarily prepaid only as permitted under Section 2.4 of the Agreement. After an Event of Default, this Note shall bear interest
at a rate per annum equal to the Default Rate pursuant to Section 2.6 of the Agreement. 
 Borrower and all parties now or hereafter liable with respect
to this Note, hereby waive presentment, demand for payment, notice of nonpayment, protest, notice of protest, notice of dishonor, and all other notices in connection herewith, as well as filing of suit (if permitted by law) and diligence in
collecting this Note or enforcing any of the security hereof, and agree to pay (if permitted by law) all expenses incurred in collection, including reasonable attorneys’ fees and expenses, including without limitation, the allocated costs of
in-house counsel. 

 THIS NOTE SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK. 
 No variation or modification of this Note, or any waiver of any of its provisions or conditions, shall be valid unless such variation or modification is made in
accordance with Section 10.8 of the Agreement. Any such waiver, consent, modification or change shall be effective only in the specific instance and for the specific purpose given. 

 IN WITNESS WHEREOF, Borrower has duly executed this Note as of the date first above written. 
  

			
	SALIENT SURGICAL TECHNOLOGIES, INC.
		
	By:	 	 /s/ Richard M. Altieri

	Name:	 	Richard M. Altieri
	Title:	 	VP and CFO
	Federal Tax ID #: 02-0510461
	Address: 1 Washington Ctr, Dover, NH

 SALIENT SURGICAL TECHNOLOGIES, INC. 
 REVOLVING LOAN PROMISSORY NOTE 
 (OXFORD) 
 Signature PageWarrant

 Exhibit 10.23(j) 
 NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. SUBJECT TO SECTION 6 BELOW, NO SALE OR DISPOSITION MAY BE EFFECTED
EXCEPT IN COMPLIANCE WITH RULE 144 UNDER SAID ACT OR WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL FOR HOLDER, SATISFACTORY TO COMPANY, THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE ACT OR RECEIPT OF A
NO-ACTION LETTER FROM THE SECURITIES AND EXCHANGE COMMISSION. 
 WARRANT TO PURCHASE 166,667 SHARES OF SERIES E CONVERTIBLE PREFERRED
STOCK 
 April 30, 2008 
 THIS
CERTIFIES THAT, for value received, Oxford Finance Corporation (“Holder”) is entitled to subscribe for and purchase One Hundred Sixty-Six Thousand Six Hundred and Sixty-Seven (166,667) shares of fully paid and nonassessable
Series E Convertible Preferred Stock of Salient Surgical Technologies, Inc., a Delaware corporation (the “Company”), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the terms and conditions hereinafter set
forth. As used herein, the term “Preferred Stock” shall mean Company’s presently authorized Series E Convertible Preferred Stock, $0.01 par value per share, and any stock into which such Preferred Stock may hereafter be converted
or exchanged and the term “Warrant Shares” shall mean the shares of Preferred Stock which Holder may acquire pursuant to this Warrant and any other shares of stock into which such shares of Preferred Stock may hereafter be converted or
exchanged; provided, however, in the event all outstanding Preferred Stock is converted into shares of Common Stock (defined below), Warrant Shares shall thereafter mean that number of shares of Common Stock into which the number of shares of
Preferred Stock for which the applicable warrant is exercisable would have converted had such Preferred Stock been issued immediately prior to the conversion. 
 1. Warrant Price. The “Warrant Price” shall initially be One and 65/100 dollars ($1.65) per share, subject to adjustment as provided in Section 7 below. 
 2. Conditions to Exercise. The purchase right represented by this Warrant may be exercised at any time, or from time to time, in whole or in part during the term commencing on the date hereof and ending at
5:00 P.M. Pacific time on the tenth anniversary of the date of this Warrant (the “Expiration Date”). 
 3. Method of Exercise or
Conversion; Payment; Issuance of Shares; Issuance of New Warrant. 
 (a) Cash Exercise. Subject to Section 2 hereof, the
purchase right represented by this Warrant may be exercised by Holder hereof, in whole or in part, by the surrender of the original of this Warrant (together with a duly executed Notice of Exercise in substantially the form attached hereto) at the
principal office of Company (as set forth in Section 19 below) and by payment to Company, by certified or bank check, or wire transfer of immediately available funds, of an amount equal to the then applicable Warrant Price per share multiplied
by the number of Warrant Shares then being purchased. In the event of any exercise of the rights represented by this Warrant, certificates for the shares of stock so purchased shall be in the name of, and delivered to, Holder hereof, or as such
Holder may direct (subject to the terms of transfer contained herein and upon payment by such Holder hereof of any applicable transfer taxes). Such delivery shall be made within 30 days after exercise of this Warrant and at 

 
Company’s expense and, unless this Warrant has been fully exercised or expired, a new Warrant having terms and conditions substantially identical to
this Warrant and representing the portion of the Warrant Shares, if any, with respect to which this Warrant shall not have been exercised, shall also be issued to Holder hereof within 30 days after exercise of this Warrant. 
 (b) Conversion. In lieu of exercising this Warrant as specified in Section 3(a), Holder may from time to time convert this Warrant, in whole
or in part, into Warrant Shares by surrender of the original of this Warrant (together with a duly executed Notice of Exercise in substantially the form attached hereto) at the principal office of Company, in which event Company shall issue to
Holder the number of Warrant Shares computed using the following formula: 
  

					
	 X =
	 	Y (A-B)	 	
		 	A	 	

 Where: 
 X = the number of Warrant Shares to be issued to Holder. 
 Y = the number of Warrant Shares purchasable under
this Warrant (at the date of such calculation). 
 A = the Fair Market Value of one share of Company’s Preferred Stock (at the date of
such calculation). 
 B = Warrant Price (as adjusted to the date of such calculation). 
 (c) Fair Market Value. For purposes of this Section 3, Fair Market Value of one share of Company’s Preferred Stock shall mean:

 (i) In the event of an exercise in connection with an initial public offering of the common stock of Company (an “Initial Public
Offering”), the per share Fair Market Value for the Preferred Stock shall be the offering price at which the underwriters initially sell common stock of Company (“Common Stock”) to the public multiplied by the number of shares of
Common Stock into which each share of Preferred Stock is then convertible; or 
 (ii) The average of the closing bid and asked prices of
Common Stock quoted in the Over-The-Counter Market Summary, the last reported sale price quoted on the Nasdaq Stock Market or on any other exchange on which the Common Stock is listed, whichever is applicable, as published in the Western Edition of
the Wall Street Journal for the three (3) trading days prior to the date of determination of Fair Market Value, multiplied by the number of shares of Common Stock into which each share of Preferred Stock is then convertible; or

 (iii) In the event of an exercise in connection with a merger, acquisition or other consolidation in which Company is not the surviving
entity, the per share Fair Market Value for the Preferred Stock shall be the value to be received per share of Preferred Stock by all holders of the Preferred Stock in such transaction as determined by the Board of Directors; or 
 (iv) In any other instance, the per share Fair Market Value for the Preferred Stock shall be as determined in the reasonable good faith judgment of
Company’s Board of Directors. 
 In the event of 3(c)(iii) or 3(c)(iv), above, Company’s Board of Directors shall prepare a
certificate, to be signed by an authorized officer of Company, setting forth in reasonable detail the basis for and method of determination of the per share Fair 

  

 2 

 
Market Value of the Preferred Stock. The Board of Directors will also certify to Holder that this per share Fair Market Value will be applicable to all
holders of Company’s Preferred Stock. Such certification must be made to Holder at least (1) ten (10) business days prior to the proposed effective date of the merger, consolidation, sale, or other triggering event as defined in
3(c)(iii) or (2) at the time of any other conversion pursuant to 3(c)(iv). 
 (d) Automatic Exercise. To the extent this Warrant
is not previously exercised, it shall be deemed to have been automatically converted in accordance with Sections 3(b) and 3(c) hereof (even if not surrendered) as of immediately before its expiration, involuntary termination or
cancellation if the then-Fair Market Value of a Warrant Share exceeds the then-Warrant Price, unless Holder notifies Company in writing to the contrary prior to such automatic exercise. 
 (e) Treatment of Warrant Upon Acquisition of Company. 
 (i) Certain Definitions. For the purpose of this Warrant, "Acquisition" means any sale, license, or other disposition of all or substantially all of the assets of Company, or any reorganization, consolidation,
or merger of Company, or sale of outstanding Company securities by holders thereof, where the holders of Company's securities before the transaction beneficially own less than a majority of the outstanding voting securities of the successor or
surviving entity after the transaction (other than an Initial Public Offering). For purposes of this Section 3(e), “Affiliate” shall mean any person or entity that owns or controls directly or indirectly ten percent (10%) or more
of the voting capital stock of Company, any person or entity that controls or is controlled by or is under common control with such persons or entities, and each of such person’s or entity’s officers, directors, joint venturers or
partners, as applicable. 
 (ii) Cash Acquisition. In the event of an Acquisition that is not a True Assets Sale (as defined below) in
which the sole consideration is cash, Holder may either (a) exercise its conversion or purchase right under this Warrant and such exercise will be deemed effective immediately prior to the consummation of such Acquisition or (b) permit the
Warrant to expire upon the consummation of such Acquisition. Company shall provide Holder with written notice of any proposed Acquisition together with such reasonable information as Holder may request in connection with such contemplated
Acquisition giving rise to such notice, which is to be delivered to Holder not less than ten (10) business days prior to the closing of the proposed Acquisition. 
 (iii) Asset Sale. In the event of an Acquisition that is an arms length sale of all or substantially all of Company’s assets (and only its assets) to a third party that is not an Affiliate of Company (a
“True Asset Sale”), Holder may either (a) exercise its conversion or purchase right under this Warrant and such exercise will be deemed effective immediately prior to the consummation of such Acquisition or (b) permit the Warrant
to continue until the Expiration Date if Company continues as a going concern following the closing of any such True Asset Sale. Company shall provide Holder with written notice of any proposed asset sale together with such reasonable information as
Holder may request in connection with such asset sale giving rise to such notice, which is to be delivered to Holder not less than ten (10) business days prior to the closing of the proposed asset sale. 
 (iv) Assumption of Warrant. Upon the closing of any Acquisition other than those particularly described in subsections (ii) and
(iii) above, the successor entity shall assume the obligations of this Warrant, and this Warrant shall be exercisable for the same securities, cash, and property as would be payable for the Warrant Shares issuable upon exercise of the 

  

 3 

 
unexercised portion of this Warrant as if such Warrant Shares were outstanding on the record date for the Acquisition and subsequent closing. The Warrant
Price and/or number of Warrant Shares shall be adjusted accordingly. 
 4. Representations and Warranties of Holder and Company. 
 (a) Representations and Warranties by Holder. Holder represents and warrants to Company with respect to this purchase as follows: 
 (i) Evaluation. Holder has substantial experience in evaluating and investing in private placement transactions of securities of companies similar
to Company so that Holder is capable of evaluating the merits and risks of its investment in Company and has the capacity to protect its interests. 
 (ii) Resale. Holder is acquiring this Warrant and the Warrant Shares issuable upon exercise of this Warrant (collectively the “Securities”) for investment for its own account and not with a view to, or for resale in
connection with, any distribution thereof. Holder understands that the Securities have not been registered under the Securities Act of 1933, as amended (the “Act”) by reason of a specific exemption from the registration provisions of the
Act which depends upon, among other things, the bona fide nature of the investment intent as expressed herein. 
 (iii) Rule 144.
Holder acknowledges that the Securities must be held indefinitely unless subsequently registered under the Act or an exemption from such registration is available. Holder is aware of the provisions of Rule 144 promulgated under the Act.

 (iv) Accredited Investor. Holder is an “accredited investor” within the meaning of Regulation D promulgated under the Act.

 (v) Opportunity To Discuss. Holder has had an opportunity to discuss Company’s business, management and financial affairs with
its management and an opportunity to review Company’s facilities. Holder understands that such discussions, as well as the written information issued by Company, were intended to describe the aspects of Company’s business and prospects
which Company believes to be material but were not necessarily a thorough or exhaustive description. 
 (b) Representations and Warranties
by Company. Company hereby represents and warrants to Holder with respect to this Warrant as follows: 
 (i) Corporate Organization and
Authority. Company (a) is a corporation duly organized, validly existing, and in good standing in its jurisdiction of incorporation, (b) has the corporate power and authority to own and operate its properties and to carry on its
business as now conducted and as proposed to be conducted; and (c) is qualified as a foreign corporation in all jurisdictions where such qualification is required. 
 (ii) Corporate Power . Company has all requisite legal and corporate power and authority to execute, issue and deliver this Warrant, to issue the Warrant Shares issuable upon exercise or conversion of this
Warrant, and to carry out and perform its obligations under this Warrant and any related agreements. 
 (iii) Authorization;
Enforceability. All corporate action on the part of Company, its officers, directors and shareholders 

  

 4 

 
necessary for the authorization, execution, delivery and performance of its obligations under this Warrant and for the authorization, issuance and delivery
of this Warrant and the Warrant Shares issuable upon exercise of this Warrant has been taken and this Warrant constitutes the legally binding and valid obligation of Company enforceable in accordance with its terms. 
 (iv) Valid Issuance of Warrant and Warrant Shares. This Warrant has been validly issued and is free of restrictions on transfer other than
restrictions on transfer set forth herein and under applicable state and federal securities laws. The Warrant Shares issuable upon conversion of this Warrant, when issued, sold and delivered in accordance with the terms of this Warrant for the
consideration expressed herein, will be duly and validly issued, fully paid and nonassessable, and will be free of restrictions on transfer other than restrictions on transfer under this Warrant and under applicable state and federal securities
laws. Subject to applicable restrictions on transfer, the issuance and delivery of this Warrant and the Warrant Shares issuable upon exercise or conversion of this Warrant are not subject to any preemptive or other similar rights or any liens or
encumbrances except as specifically set forth in Company’s Certificate of Incorporation or this Warrant. The offer, sale and issuance of the Warrant Shares, as contemplated by this Warrant, are exempt from the prospectus and registration
requirements of applicable United States federal and state security laws, and neither Company nor any authorized agent acting on its behalf has or will take any action hereafter that would cause the loss of such exemption. 
 (v) No Conflict. The execution, delivery, and performance of this Warrant will not result in (a) any violation of, be in conflict with, or
constitute a default under, with or without the passage of time or the giving of notice (1) any provision of Company’s Certificate of Incorporation or by-laws; (2) any provision of any judgment, decree, or order to which Company is a
party, by which it is bound, or to which any of its material assets are subject; (3) any contract, obligation, or commitment to which Company is a party or by which it is bound; or (4) any statute, rule, or governmental regulation
applicable to Company, or (b) the creation of any lien, charge or encumbrance upon any assets of Company. 
 (vi) Capitalization.
The capitalization table of Company attached hereto as Annex A is complete and accurate as of December 31, 2007 and reflects (a) all outstanding capital stock of Company and (b) all outstanding warrants and options to purchase or
otherwise acquire any equity securities or convertible securities of Company. Company has reserved 166,667 shares of Common Stock for issuance upon conversion of the Preferred Stock. 
 (vii) Warrant Price. The Warrant Price is no greater than the lowest price at which Company has issued Series E Convertible Preferred Stock to an
unrelated third party in an arm’s length transaction, other than (x) the issuance on February 12, 2007 of 27,346,379 shares of Series E Convertible Preferred Stock to 26 accredited investors at the price of $0.924 per share,
(y) the issuance on September 1, 2006 of warrants to purchase 1,995,478 shares of Series E Convertible Preferred Stock to 20 accredited investors at the exercise price of $0.01 per share, and (z) the issuance on September 1, 2006
of warrants to purchase 162,338 shares of Series E Convertible Preferred Stock to each of Horizon Technology Funding Company II LLC and Horizon Technology Funding Company III LLC at the exercise price of $0.924 per share. 
  

	5.	Legends. 

 (a) Legend. Each certificate
representing the Warrant Shares shall be endorsed with substantially the following legend: 
 THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933 AND MAY NOT BE TRANSFERRED (UNLESS SUCH TRANSFER IS TO AN AFFILIATE OF HOLDER) UNLESS COVERED BY AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT, A “NO ACTION” LETTER FROM THE SECURITIES AND EXCHANGE
COMMISSION WITH RESPECT TO SUCH TRANSFER, A TRANSFER MEETING THE REQUIREMENTS OF RULE 144 OF THE SECURITIES AND EXCHANGE COMMISSION, OR (IF REASONABLY REQUIRED BY COMPANY) AN OPINION OF COUNSEL SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY
SUCH TRANSFER IS EXEMPT FROM SUCH REGISTRATION. 
  

 5 

 Company need not enter into its stock records a transfer of Warrant Shares unless the conditions
specified in the foregoing legend are satisfied. Company may also instruct its transfer agent not to allow the transfer of any of the Warrant Shares unless the conditions specified in the foregoing legend are satisfied. 
 (b) Removal of Legend and Transfer Restrictions. The legend relating to the Act endorsed on a certificate pursuant to paragraph 5(a) of this
Warrant shall be removed and Company shall issue a certificate without such legend to Holder if (i) the Securities are registered under the Act and a prospectus meeting the requirements of Section 10 of the Act is available or
(ii) Holder provides to Company an opinion of counsel for Holder reasonably satisfactory to Company, a no-action letter or interpretive opinion of the staff of the Securities and Exchange Commission (“SEC”) reasonably satisfactory to
Company, or other evidence reasonably satisfactory to Company, to the effect that public sale, transfer or assignment of the Securities may be made without registration and without compliance with any restriction such as Rule 144. 

6. Condition of Transfer or Exercise of Warrant. It shall be a condition to any transfer or exercise of this Warrant that at the time of such transfer or
exercise, Holder shall provide Company with a representation in writing that Holder or transferee is acquiring this Warrant and the shares of Preferred Stock to be issued upon exercise for investment purposes only and not with a view to any sale or
distribution, or will provide Company with a statement of pertinent facts covering any proposed distribution. As a further condition to any transfer of this Warrant or any or all of the shares of Preferred Stock issuable upon exercise of this
Warrant, other than a transfer registered under the Act, Company may request a legal opinion, in form and substance satisfactory to Company and its counsel, reciting the pertinent circumstances surrounding the proposed transfer and stating that such
transfer is exempt from the registration and prospectus delivery requirements of the Act. Company shall not require Holder to provide an opinion of counsel if the transfer is to an affiliate of Holder. As further condition to each transfer, at the
request of Company, Holder shall surrender this Warrant to Company and the transferee shall receive and accept a Warrant, of like tenor and date, executed by Company. It shall also be a condition to any transfer or exercise of this Warrant that at
the time of such transfer or exercise Holder shall provide Company with a representation in writing that Holder is in compliance with the provisions concerning transfer restrictions contained in the Investors’ Rights Agreement (defined below)
with respect to such transfer or exercise. 
 7. Adjustment for Certain Events. The number and kind of securities purchasable upon the exercise of
this Warrant and the Warrant Price shall be subject to adjustment from time to time upon the occurrence of certain events, as follows: 
 (a)
Reclassification or Merger. In case of (i) any reclassification or change of securities of the class issuable upon exercise of this Warrant (other than a change in par value, or from par value to no par value, or from no par value to par
value, or as a result of a subdivision or combination), (ii) any merger of Company with or into another corporation (other than a merger with another 

  

 6 

 
corporation in which Company is the acquiring and the surviving corporation and which does not result in any reclassification or change of outstanding
securities issuable upon exercise of this Warrant), or (iii) any sale of all or substantially all of the assets of Company, Company, or such successor or purchasing corporation, as the case may be, shall duly execute and deliver to Holder a new
Warrant (in form and substance satisfactory to Holder of this Warrant), or Company shall make appropriate provision without the issuance of a new Warrant, so that Holder shall have the right to receive, at a total purchase price not to exceed that
payable upon the exercise of the unexercised portion of this Warrant, and in lieu of the Warrant Shares theretofore issuable upon exercise or conversion of this Warrant, the kind and amount of shares of stock, other securities, money and property
receivable upon such reclassification, change, merger or sale by a holder of the number of shares of Preferred Stock then purchasable under this Warrant, or in the case of such a merger or sale in which the consideration paid consists all or in part
of assets other than securities of the successor or purchasing corporation, at the option of Holder, the securities of the successor or purchasing corporation having a value at the time of the transaction equivalent to the value of the Warrant
Shares purchasable upon exercise of this Warrant at the time of the transaction. Any new Warrant shall provide for adjustments that shall be as nearly equivalent as may be practicable to the adjustments provided for in this Section 7. The
provisions of this subparagraph (a) shall similarly apply to successive reclassifications, changes, mergers and transfers. 
 (b)
Subdivision or Combination of Shares. If Company at any time while this Warrant remains outstanding and unexpired shall subdivide or combine its outstanding shares of Preferred Stock, the Warrant Price shall be proportionately decreased and
the number of Warrant Shares issuable hereunder shall be proportionately increased in the case of a subdivision and the Warrant Price shall be proportionately increased and the number of Warrant Shares issuable hereunder shall be proportionately
decreased in the case of a combination. 
 (c) Stock Dividends and Other Distributions. If Company at any time while this Warrant is
outstanding and unexpired shall (i) pay a dividend with respect to Preferred Stock payable in Preferred Stock, then the Warrant Price shall be adjusted, from and after the date of determination of shareholders entitled to receive such dividend
or distribution, to that price determined by multiplying the Warrant Price in effect immediately prior to such date of determination by a fraction (A) the numerator of which shall be the total number of shares of Preferred Stock outstanding
immediately prior to such dividend or distribution, and (B) the denominator of which shall be the total number of shares of Preferred Stock outstanding immediately after such dividend or distribution; or (ii) make any other distribution
with respect to Preferred Stock (except any distribution specifically provided for in Sections 7(a) and 7(b)), then, in each such case, provision shall be made by Company such that Holder shall receive upon exercise of this Warrant a
proportionate share of any such dividend or distribution as though it were Holder of the Warrant Shares as of the record date fixed for the determination of the shareholders of Company entitled to receive such dividend or distribution. 

(d) Adjustment of Number of Shares. Upon each adjustment in the Warrant Price, the number of Warrant Shares purchasable hereunder shall be
adjusted, to the nearest whole share, to the product obtained by multiplying the number of Warrant Shares purchasable immediately prior to such adjustment in the Warrant Price by a fraction, the numerator of which shall be the Warrant Price
immediately prior to such adjustment and the denominator of which shall be the Warrant Price immediately thereafter. 
 (e) Adjustment for
Dilutive Issuance. The Warrant Price and the number of Warrant Shares issuable upon exercise of this Warrant or, if the Warrant Shares are Preferred Stock, the number of shares of Common Stock issuable upon conversion of the 

  

 7 

 
Warrant Shares, shall be subject to adjustment, from time to time in the manner set forth in Company’s Certificate of Incorporation as if the Warrant
Shares were issued and outstanding on and as of the date of any such required adjustment. The provisions set forth for the Warrant Shares in Company’s Certificate of Incorporation relating to the above in effect as of the date hereof may not be
amended, modified or waived, without the prior written consent of Holder unless such amendment, modification or waiver affects the rights associated with the Warrant Shares in the same manner as such amendment, modification or waiver affects the
rights associated with all other shares of the same series and class as the Warrant Shares. 
 (f) Adjustment for Pay-to-Play
Transaction. In the event that Company’s Certificate of Incorporation provides, or is amended to so provide, for the amendment or modification of the rights, preferences or privileges of the Preferred Stock, or the reclassification,
conversion or exchange of the Preferred Stock, in the event that a holder thereof fails to participate in an equity financing transaction (a “Pay-to-Play Provision”), and in the event that such Pay-to-Play Provision becomes operative, this
Warrant shall automatically and without any action required become exercisable for that number and type of shares of equity securities as would have been issued or exchanged, or would have remained outstanding, in respect of the Warrant Shares
issuable hereunder had this Warrant been exercised in full prior to such event, and had Holder participated in the equity financing to the maximum extent permitted. 
 8. Notice of Adjustments. Whenever any Warrant Price or the kind or number of securities issuable under this Warrant shall be adjusted pursuant to Section 7 hereof, Company shall prepare a certificate
signed by an officer of Company setting forth, in reasonable detail, the event requiring the adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the Warrant Price and number or kind of shares issuable
upon exercise of this Warrant after giving effect to such adjustment, and shall cause copies of such certificate to be mailed (by certified or registered mail, return receipt required, postage prepaid) within thirty (30) days of such
adjustment to Holder as set forth in Section 19 hereof. 
 9. Financial and Other Reports. From time to time up to the earlier of the Expiration
Date or the complete exercise of this Warrant, Company shall furnish to Holder such financial reports, if any, as are required to be delivered to the Investors, as that term is defined in the Investors’ Rights Agreement (defined below),
pursuant to Section 6.3 of the Investors’ Rights Agreement. 
 10. Transferability of Warrant. This Warrant is transferable on the books of
Company at its principal office by the registered Holder hereof upon surrender of this Warrant properly endorsed, subject to compliance with Section 6 and applicable federal and state securities laws. Company shall issue and deliver to the
transferee a new Warrant representing the Warrant so transferred. Upon any partial transfer, Company will issue and deliver to Holder a new Warrant with respect to the Warrant not so transferred. Holder shall not have any right to transfer any
portion of this Warrant to any direct competitor of Company. 
 11. Registration Rights. Pursuant to a separate Joinder Agreement dated on or about
the date hereof executed by Company and Holder, Company grants registration rights to Holder for any Common Stock obtained upon exercise of this Warrant, or conversion of the Preferred Stock, comparable to the registration rights granted to the
investors in that certain Investors’ Rights Agreement dated as of February 12, 2007 (the “Investors’ Rights Agreement”), with the following exceptions and clarifications, all as set forth in and subject to the
above-referenced Joinder Agreement: 
 (1) Holder will not have the right to demand registration, but can otherwise
participate in any registration demanded by others in accordance with the terms of the Investors’ Rights Agreement. 
  

 8 

 (2) Holder will be subject to the same provisions regarding indemnification as contained
in the Investors’ Rights Agreement. 
 (3) The registration rights are freely assignable by Holder in connection with a
permitted transfer of this Warrant or the Warrant Shares. 
 12. No Fractional Shares. No fractional share of Preferred Stock will be issued in
connection with any exercise or conversion hereunder, but in lieu of such fractional share Company shall make a cash payment therefor upon the basis of the Warrant Price then in effect. 
 13. Charges, Taxes and Expenses. Issuance of certificates for shares of Preferred Stock upon the exercise or conversion of this Warrant shall be made without charge to Holder for any United States or state of
the United States documentary stamp tax or other incidental expense with respect to the issuance of such certificate, all of which taxes and expenses shall be paid by Company, and such certificates shall be issued in the name of Holder. 

14. No Shareholder Rights Until Exercise. Except as expressly provided herein, this Warrant does not entitle Holder to any voting rights or other rights as a
shareholder of Company prior to the exercise hereof. 
 15. Registry of Warrant. Company shall maintain a registry showing the name and address of the
registered Holder of this Warrant. This Warrant may be surrendered for exchange or exercise, in accordance with its terms, at such office or agency of Company, and Company and Holder shall be entitled to rely in all respects, prior to written notice
to the contrary, upon such registry. 
 16. Loss, Theft, Destruction or Mutilation of Warrant. Upon receipt by Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant, and, in the case of loss, theft, or destruction, of indemnity reasonably satisfactory to it, and, if mutilated, upon surrender and cancellation of this Warrant,
Company will execute and deliver a new Warrant, having terms and conditions substantially identical to this Warrant, in lieu hereof. 
 17.
Miscellaneous. 
 (a) Issue Date. The provisions of this Warrant shall be construed and shall be given effect in all respect as
if it had been issued and delivered by Company on the date hereof. 
 (b) Successors. This Warrant shall be binding upon any successors
or assigns of Company. 
 (c) Headings. The headings used in this Warrant are used for convenience only and are not to be considered in
construing or interpreting this Warrant. 
 (d) Saturdays, Sundays, Holidays. If the last or appointed day for the taking of any action
or the expiration of any right required or granted herein shall be a Saturday or a Sunday or shall be a legal holiday in the State of New York, then such action may be taken or such right may be exercised on the next succeeding day not a legal
holiday. 
 (e) Attorney’s Fees. In the event of any dispute between the parties concerning the terms and provisions of this
Warrant, the party prevailing in such dispute shall be entitled to collect from the other party all costs incurred in such dispute, including reasonable attorney’s fees. 
 18. No Impairment. Company will not, by amendment of its Certificate of Incorporation or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but
will at all times in good faith assist in the carrying out of all such terms and in the taking of all such action as may be necessary or appropriate in order to protect the rights of Holder hereof 

  

 9 

 
against impairment. Without limiting the breadth of the foregoing, Company will not cause the Series E Convertible Preferred Stock into which this Warrant is
exercisable or convertible to be converted into Common Stock unless such conversion is effected as part of the conversion of all Company’s outstanding series of preferred stock into Common Stock. 
 19. Addresses. Any notice required or permitted hereunder shall be in writing and shall be mailed by overnight courier, registered or certified mail, return
receipt requested, and postage prepaid, or otherwise delivered by hand or by messenger, addressed as set forth below, or at such other address as Company or Holder hereof shall have furnished to the other party in accordance with the delivery
instructions set forth in this Section 19. 
  

			
	 If to Company:
	  	Salient Surgical Technologies, Inc.
		  	One Washington Center, Suite 400
		  	Dover, NH 03820
		  	Attn: Rick Altieri
		
	 With a copy to:
	  	Ropes & Gray LLP
		  	One International Place
		  	Boston, MA 02110
		  	Attn: Michael F. Sexton
		
	 If to Holder:
	  	Oxford Finance Corporation
		  	133 North Fairfax Street
		  	Alexandria, VA 22314
		  	Attn: Timothy A. Lex
		  	Executive Vice President and Chief Operating Officer

 If mailed by registered or certified mail, return receipt requested, and postage prepaid, notice
shall be deemed to be given five (5) days after being sent, and if sent by overnight courier, by hand or by messenger, notice shall be deemed to be given when delivered (if on a business day, and if not, on the next business day). 

20. WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY
IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS WARRANT OR THE WARRANT SHARES. 
 21. GOVERNING
LAW. THIS WARRANT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. 
 [Remainder of page
intentionally left blank] 
  

 10 

 IN WITNESS WHEREOF, Company has caused this Warrant to be executed by its officer thereunto duly
authorized. 
  

			
	SALIENT SURGICAL TECHNOLOGIES, INC.
		
	By:	 	 /s/ Richard M. Altieri

	Name:	 	Richard M. Altieri
	Title:	 	VP and CFO

 Dated as of April 30, 2008 
 SALIENT SURGICAL TECHNOLOGIES, INC. 
 NEW WARRANT (OXFORD) 
 Signature Page 

 NOTICE OF EXERCISE 
 To: 
 Salient Surgical Technologies, Inc. 
 One Washington Center, Suite 400 
 Dover, NH 03820 
 Attn: Rick Altieri 
  

	1.	The undersigned Warrantholder (“Holder”) elects to acquire shares of the Series E Convertible Preferred Stock (the “Preferred Stock”) of Salient Surgical
Technologies, Inc. (the “Company”), pursuant to the terms of the Stock Purchase Warrant dated             , 200     (the
“Warrant”). 

  

	2.	Holder exercises its rights under the Warrant as set forth below: 

  

			
	(            )	  	Holder elects to purchase              shares of Preferred Stock as provided in Section 3(a) and tenders herewith a
check in the amount of $             as payment of the purchase price.
		
	(            )	  	Holder elects to convert the purchase rights into shares of Preferred Stock as provided in Section 3(b) of the Warrant.

  

	3.	Holder surrenders the Warrant with this Notice of Exercise. 

 Holder
represents that it is acquiring the aforesaid shares of Preferred Stock for investment and not with a view to or for resale in connection with distribution and that Holder has no present intention of distributing or reselling the shares. 

Holder represents that it is in compliance with the provisions concerning transfer restrictions contained in the Investors’ Rights Agreement with respect to this
exercise. 
 Please issue a certificate representing the shares of the Preferred Stock in the name of Holder or in such other name as is specified below:

  

											
		 	Name:	 	  
	 		 	
		 	Address:	 	  
	 		 	
		 	Taxpayer I.D.:	 	  
	 		 	

  

			
	[OXFORD FINANCE CORPORATION]
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	Date:	 	                    
    , 200

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}]]